How FDA Approval of on! PLUS Pouches Will Impact Altria Group (MO) Investors

In late 2025, the FDA granted marketing authorization for six on! PLUS nicotine pouch products made by Altria Group’s Helix ...

Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates

The Company enters 2026 with Multiple Phase 2 Catalysts collectively representing ~$8 billion in potential market ...

Goldman Sees Growth Catalyst for Altria Group, Inc. (MO) After FDA Approval of on! PLUS

We recently compiled a list of the 10 Best Long-Term Investments for Kids. Altria Group, Inc. stands tenth among the best ...